Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.

Wordsworth P. and Chan M., (2019), Calcif Tissue Int, 104, 530 - 543

Susceptibility to ankylosing spondylitis is influenced independently by two closely adjacent RUNX3 single nucleotide polymorphisms that show strong functional effect in different cell types

(2019), Rheumatology

The association of a common functional polymorphism in the tumour necrosis factor receptor 1 gene (TNFRSF1A) and disease severity in ankylosing spondylitis

(2019), Rheumatology

OP0231?Differential transcription factor binding could explain the genetic association of ankylosing spondylitis with polymorphisms in the IL23R-IL12RB2 intergenic region

(2018), Annals of the Rheumatic Diseases

OP0299?Susceptibility to ankylosing spondylitis is influenced independently by two closely adjacent Runx3 Snps, that show strong functional effect in different cell types

(2018), Annals of the Rheumatic Diseases

THU0364?Rare ERAP1 allotype combinations do not explain the ERAP1 association with ankylosing spondylitis

(2018), Annals of the Rheumatic Diseases

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.

Ntusi NAB. et al, (2018), Int J Cardiol, 270, 253 - 259

Quantifying the genetic risk for the development of axial spondyloarthropathy: could this become a diagnostic tool?

Wordsworth BP. et al, (2018), Current opinion in rheumatology, 30, 319 - 323

Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism.

Vecellio M. et al, (2018), RMD open, 4, e000628 - e000628

Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.

Ntusi NAB. et al, (2018), Hellenic J Cardiol

The severity of AS and responses to anti-TNF biologics are not influenced by the TNF receptor polymorphism incriminated in MS

Vecellio M. et al, (2018), Genes and Immunity

NOVEL INSIGHTS INTO THE CHARACTERISTICS AND IMPACT OF BONE PAIN IN ADULTS WITH FIBROUS DYSPLASIA

Watts L. et al, (2017), OSTEOPOROSIS INTERNATIONAL, 28, S244 - S244

Investigation of a possible extended risk haplotype in the IL23R region associated with ankylosing spondylitis

Wordsworth BP. et al, (2017), Genes and Immunity

Reply to Reeves et al.: No evidence for rare ERAP1 haplotypes and haplotype combinations in ankylosing spondylitis.

Wordsworth BP. et al, (2017), Proceedings of the National Academy of Sciences of the United States of America, 114, E1577 - E1577

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation.

Roberts AR. et al, (2016), Ann Rheum Dis, 75, 2150 - 2156

ERAP1 association with ankylosing spondylitis is attributable to common genotypes rather than rare haplotype combinations

Wordsworth BP. et al, (2016), Proceedings of the National Academy of Sciences (USA)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.

Forestier-Zhang L. et al, (2016), Orphanet J Rare Dis, 11, 160 - 160

The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases

Javaid MK. et al, (2016), Orphanet Journal of Rare Diseases

Genetics of ankylosing spondylitis--insights into pathogenesis.

Brown MA. et al, (2016), Nat Rev Rheumatol, 12, 81 - 91

Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.

Baraliakos X. et al, (2016), Ann Rheum Dis, 75, 408 - 412

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?